U.S. Remote Patient Monitoring System Market Size, Share, Trends, Industry Analysis Report By Product (Vital Sign Monitors, Special Monitors), By End Use, By Application

Description

List of Tables

The U.S. remote patient monitoring system market size is expected to reach USD 11.81 billion by 2034, according to a new study by Polaris Market Research. The report "U.S. Remote Patient Monitoring System Market Size, Share, Trends, Industry Analysis Report By Product (Vital Sign Monitors, Special Monitors), By End Use, By Application - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Remote patient monitoring, or RPM, is a type of healthcare technology that uses devices to collect health data from a patient's location and send it to a healthcare provider. The RPM system helps in tracking vital signs such as blood pressure, heart rate, and blood oxygen levels. The goal is to let doctors and nurses monitor a patient's condition without the need for an in-person visit. This technology is especially useful for managing chronic conditions, helping with post-operative recovery, and providing care to older adults. By using RPM, patients can be more involved in their own health management, and healthcare professionals can make faster decisions based on real-time data.

The U.S. remote patient monitoring system market growth is driven by the rising incidence of chronic diseases and an aging population. This growth is also being fueled by the increasing use of telehealth services and favorable reimbursement policies. The market includes a wide range of devices, from simple blood pressure cuffs to more complex continuous glucose monitors and cardiac monitors. There is also a strong focus on developing software and apps that can analyze the data and make it easier for both patients and providers to use. This combination of factors is pushing the market forward and changing how healthcare is delivered, making it more accessible and patient-focused.

U.S. Remote Patient Monitoring System Market Report Highlights:

By product, the special monitors segment held the largest share in 2024, due to the wide variety of devices that track complex and specific health conditions, which is essential for managing chronic diseases and preventing complications.

Based on end use, the hospital-based patients segment held the largest share in 2024. Hospitals use this technology to manage a large number of patients, both in-patient and out-patient, which helps in making faster decisions and preventing re-admissions.

By application, the diabetes application segment held the largest share in 2024. The high prevalence of this chronic condition in the U.S. requires constant monitoring of blood glucose levels, making remote patient monitoring a vital tool for patients and doctors.

A few key players in the U.S. remote patient monitoring system market include BioIntelliSense, Inc.; Boston Scientific Corporation; Dexcom, Inc.; Health Recovery Solutions; Medtronic (Medtronic Care Management Services); OMRON Healthcare, Inc.; Oracle (Cerner); Teladoc Health; and VitalConnect.

Polaris Market Research has segmented the U.S. remote patient monitoring system market report on the basis of product, end use, and application:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Vital Sign Monitors

Blood Pressure Monitors

Pulse Oximeters

Heart Rate Monitor (ECG)

Temperature Monitor

Respiratory Rate Monitor

Brain Monitoring (EEG)

Special Monitors

Anesthesia Monitors

Blood Glucose Monitors

Cardiac Rhythm Monitor

Respiratory Monitor

Fetal Heart Monitors

Prothrombin Monitors

Multi Parameter Monitors (MPM)

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals Based Patients

Ambulatory Patients

Home Healthcare

By Application Outlook (Revenue - USD Billion, 2020-2034)

Cancer

Cardiovascular Diseases

Diabetes

Sleep Disorder

Weight management & Fitness Monitoring

Bronchitis

Infections

Virus

Dehydration

Hypertension

Product Code: PM6207

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. U.S. Remote Patient Monitoring System Market Insights

4.1. U.S. Remote Patient Monitoring System Market - Market Snapshot
4.2. U.S. Remote Patient Monitoring System Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. The Growing Burden of Chronic Diseases
  - 4.2.1.2. Increasing Aging Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Data privacy, cybersecurity risks, and regulatory complexity
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Remote Patient Monitoring System Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. U.S. Remote Patient Monitoring System Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Remote Patient Monitoring System Market, by Product, 2020-2034 (USD Billion)
5.3. Vital Sign Monitors
- 5.3.1. U.S. Remote Patient Monitoring System Market, by Vital Sign Monitors, by Region, 2020-2034 (USD Billion)
- 5.3.2. Blood Pressure Monitors
- 5.3.3. Pulse Oximeters
- 5.3.4. Heart Rate Monitor (ECG)
- 5.3.5. Temperature Monitor
- 5.3.6. Respiratory Rate Monitor
- 5.3.7. Brain Monitoring (EEG)
5.4. Special Monitors
- 5.4.1. U.S. Remote Patient Monitoring System Market, by Special Monitors, by Region, 2020-2034 (USD Billion)
- 5.4.2. Anesthesia Monitors
- 5.4.3. Blood Glucose Monitors
- 5.4.4. Cardiac Rhythm Monitor
- 5.4.5. Respiratory Monitor
- 5.4.6. Fetal Heart Monitors
- 5.4.7. Prothrombin Monitors
- 5.4.8. Multi Parameter Monitors (MPM)
- 5.4.9. Others

6. U.S. Remote Patient Monitoring System Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Remote Patient Monitoring System Market, by End Use, 2020-2034 (USD Billion)
6.3. Hospitals Based Patients
- 6.3.1. U.S. Remote Patient Monitoring System Market, by Hospitals Based Patients, by Region, 2020-2034 (USD Billion)
6.4. Ambulatory Patients
- 6.4.1. U.S. Remote Patient Monitoring System Market, by Ambulatory Patients, by Region, 2020-2034 (USD Billion)
6.5. Home Healthcare
- 6.5.1. U.S. Remote Patient Monitoring System Market, by Home Healthcare, by Region, 2020-2034 (USD Billion)

7. U.S. Remote Patient Monitoring System Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Remote Patient Monitoring System Market, by Application, 2020-2034 (USD Billion)
7.3. Cancer
- 7.3.1. U.S. Remote Patient Monitoring System Market, by Cancer, by Region, 2020-2034 (USD Billion)
7.4. Cardiovascular Diseases
- 7.4.1. U.S. Remote Patient Monitoring System Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
7.5. Diabetes
- 7.5.1. U.S. Remote Patient Monitoring System Market, by Diabetes, by Region, 2020-2034 (USD Billion)
7.6. Sleep Disorder
- 7.6.1. U.S. Remote Patient Monitoring System Market, by Sleep Disorder, by Region, 2020-2034 (USD Billion)
7.7. Weight management & Fitness Monitoring
- 7.7.1. U.S. Remote Patient Monitoring System Market, by Weight management & Fitness Monitoring, by Region, 2020-2034 (USD Billion)
7.8. Bronchitis
- 7.8.1. U.S. Remote Patient Monitoring System Market, by Bronchitis, by Region, 2020-2034 (USD Billion)
7.9. Infections
- 7.9.1. U.S. Remote Patient Monitoring System Market, by Infections, by Region, 2020-2034 (USD Billion)
7.10. Virus
- 7.10.1. U.S. Remote Patient Monitoring System Market, by Virus, by Region, 2020-2034 (USD Billion)
7.11. Hypertension
- 7.11.1. U.S. Remote Patient Monitoring System Market, by Hypertension, by Region, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. BioIntelliSense, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Boston Scientific Corporation
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Dexcom, Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Health Recovery Solutions
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Medtronic (Medtronic Care Management Services)
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. OMRON Healthcare, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Oracle (Cerner)
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Teladoc Health
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. VitalConnect
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development